文献速递急性肾损伤

肠道Toll样受体9缺陷导致潘氏细胞增生并加重缺血再灌注后的肾、肠、肝损伤

Intestinal Toll-like receptor 9 deficiency leads to Paneth cell hyperplasia and exacerbates kidney, intestine, and liver injury after ischemia/reperfusion injury.
PubMed 文献 · Kidney Int · 2019-02-15

本研究利用肠道上皮特异性TLR9缺陷小鼠(TLR9fl/fl Villin Cre)与对照小鼠,在右肾切除加左肾缺血再灌注模型下观察。意外发现肠道TLR9缺陷加重肾、肝、小肠损伤,表现为炎症、凋亡和坏死增加,潘氏细胞颗粒增大、肠道巨噬细胞浸润和IL-17A表达升高。给予IL-17A中和抗体可预防缺血性AKI加重。

要点

  • 肠道TLR9缺陷加重缺血再灌注后的肾、肠、肝多器官损伤
  • 肠道TLR9缺陷导致潘氏细胞颗粒增大、IL-17A表达升高
  • IL-17A中和抗体可逆转肠道TLR9缺陷小鼠的AKI加重

核心结论

  • 肠道TLR9激活通过调节潘氏细胞IL-17A合成保护缺血性AKI及相关远程多器官功能障碍。

研究设计与样本

  • 研究生成肠道上皮特异性TLR9缺陷小鼠(TLR9fl/fl Villin Cre)与野生型对照(TLR9fl/fl),行右肾切除加左肾缺血再灌注。

主要发现

  • 肠道TLR9缺陷小鼠较野生型小鼠肾、肝、小肠损伤加重,肾和肠道炎症、凋亡、坏死增加,肝炎症和凋亡增加。
  • 肠道TLR9缺陷小鼠潘氏细胞颗粒较大,肠道巨噬细胞浸润明显,肠隐窝IL-17A表达升高。
  • 给予IL-17A中和抗体可预防肠道TLR9缺陷小鼠缺血性AKI加重。

临床怎么用

  • 提示肠道TLR9-Paneth细胞-IL-17A轴可能是缺血性AKI及远程器官损伤的干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intestinal Paneth cells play a critical role in ischemic acute kidney injury (AKI) by releasing interleukin 17A (IL-17A). Because Toll-like receptor 9 (TLR9) activation degranulates Paneth cells and necrotic tubular epithelial cells release several damage associated molecular patterns that target TLR9, we tested the hypothesis that intestinal TLR9 deficiency would protect against ischemic AKI and associated remote intestinal and hepatic dysfunction by decreasing Paneth cell degranulation. We generated mice lacking TLR9 in intestinal epithelia (TLR9fl/fl Villin Cre mice) and compared them to wild type (TLR9fl/fl) mice following right nephrectomy and left ischemia/reperfusion. To our surprise, mice lacking intestinal TLR9 had exacerbated kidney, liver, and small intestine injury after ischemia/reperfusion compared to wild type mice, characterized by increased kidney and intestinal inflammation, apoptosis, and necrosis as well as increased hepatic inflammation and apoptosis. Mice lacking intestinal TLR9 had larger Paneth cell granule size, pronounced intestinal macrophage infiltration, and higher intestinal crypt IL-17A expression. Administration of IL-17A neutralizing antibody prevented the exacerbation of ischemic AKI in mice lacking intestinal TLR9. These studies suggest that intestinal TLR9 activation protects against ischemic AKI and associated remote multi-organ dysfunction syndrome by regulating Paneth cell IL-17A synthesis.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Han SJ, Li H, Kim M, et al. Intestinal Toll-like receptor 9 deficiency leads to Paneth cell hyperplasia and exacerbates kidney, intestine, and liver injury after ischemia/reperfusion injury. Kidney Int. 2019. PMID: 30777286. doi:10.1016/j.kint.2018.10.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。